Despite a large volume of preclinical data suggesting a favourable safety profile and therapeutic potential, BPC-157 remains an investigational compound, not approved for human use by any global drug regulatory agency, and its use is prohibited in competitive sports
GHS peptides may also cause fluid retention in the hands, feet, and ankles
Clinical Trials Requires FDA IND (Investigational New Drug) application IRB (Institutional Review Board) oversight Strict protocols and monitoring This is RESEARCH, not treatment 2
Summary of Research Applications Promotes the recovery of soft tissue injuries Heals wounds faster Collagen production Joint pain relief Neuroprotective effects Cardiovascular health Anti-inflammatory Gastrointestinal health Mitigates side effects of drugs Influence on angiogenesis CCD (Colony Collapse Disorder) in honey bees Buy BPC-157 Pre-Mixed Peptide Pen to eliminate the need for reconstitution
Evidence for Other Neuropathic Conditions B12 is also studied for other neuropathic conditions
After 1 h of administration, the copper peptides from the CaT-ME and CaT groups had reached the hair follicle region, while those from the PBS group remained outside the stratum corneum
